Navigation Links
MyChart use skyrocketing among cancer patients, UT Southwestern study finds
Date:7/9/2014

DALLAS July 9, 2014 There has been a sharp increase in the number of cancer patients at UT Southwestern Medical Center using MyChart, the online, interactive service that allows patients to view laboratory and radiology results, communicate with their healthcare providers, schedule appointments, and renew prescriptions.

Over a six-year period, the number of patients actively using MyChart each year increased five-fold, while the number of total logins each year increased more than 10-fold, according to a study by Dr. David Gerber, Associate Professor of Internal Medicine, and Dr. Simon J. Craddock Lee, Assistant Professor of Clinical Sciences.

"This pattern suggests that not only are far more patients using this technology, but also that they are using it more intensively," Dr. Gerber said.

These findings, published in the Journal of Oncology Practice, are noteworthy because no prior study has systematically examined the use of electronic patient portals by patients with cancer, even though use of this technology is surging nationwide, creating new terrain in clinical care and doctor-patient relationships.

The increase in MyChart use reflects the convenience and ease of use perceived by patients.

Darla Robinson, a 75-year-old Arlington resident with lung cancer, said she uses MyChart to follow up on her appointments with Dr. Gerber and other UT Southwestern doctors. Her husband, Jim, navigates the MyChart pages and types in any messages she wants to send to her caregivers.

"It's very efficient for finding your appointments and any information about your tests after you see the doctor," she said. "It's no hassle. It's user friendly."

In 2009, Congress allotted
'/>"/>

Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. New App Empowers Hospital Patients: Catholic Health Partners First in the Nation with MyChart Bedside
2. Ivalua Anticipates Skyrocketing 2013 Revenue on Large US Customer Wins, Becoming a Key Player in the American Spend Management Software Market
3. Neuropathy Skyrocketing in the United States - Neuracel Launches the Most Valuable Natural Treatment
4. Neuropathy in U.S. Skyrocketing
5. A new approach for controlling the skyrocketing cost of health care
6. Research says TB infection may be underestimated among people taking corticosteroid pills
7. Among weight loss methods, surgery and drugs achieve highest patient satisfaction
8. Miriam Hospital researchers analyze AUDs, sexual behavior among South African men
9. Menthol cigarettes linked to increased smoking among teens
10. Emerging HIV epidemics among people who inject drugs in the Middle East and North Africa
11. Migrating north may trigger immediate health declines among Mexicans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MyChart use skyrocketing among cancer patients, UT Southwestern study finds
(Date:10/22/2014)... MI (PRWEB) October 22, 2014 ... Schools of Allied Health Professions (ASAHP) Conference on October ... and CEO will participate in a panel discussion on ... Practice. , Isabel Healthcare provides a diagnostic decision support ... improving the diagnosis skills of students and clinical learners. ...
(Date:10/22/2014)... 22, 2014 The Louis ... is dedicated to distribute health information technology innovation ... worldwide announced the development of six key guiding ... when receiving healthcare. These are an expansion of ... “providing care that is respectful of and responsive ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... By Maureen Salamon ... -- A crucial part of conventional in vitro fertilization (IVF) ... can instead take place in a device inside the vagina, ... Colombia contend that the device, called an INVOcell, might sharply ... could also make the technology more accessible to those who ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... Online Resource for Sharing Product, Educational Expertise,with ... B. Braun Medical Inc. (B.,Braun) has launched ... services,and educational and editorial information for ambulatory ... ), The new online resource, ...
... RALEIGH, N.C., Oct. 30 TeleHealth Services, Inc., ... healthcare,market, has named Matthew K. Barker to the ... will include strategic market planning,market research and analysis., ... Mr. Barker,to direct its marketing efforts for its ...
... Scheduled for Monday, November 3, 2008, ALEXANDRIA, Va., ... League (TSCL) filed an amicus brief in support of ... right to,damages for the amputation of her gangrenous arm ... Wyeth, with the wholehearted backing of the Food ...
... Oct. 30 Arno Therapeutics,Inc. (OTC Bulletin Board: ... today announced the appointment,of William F. Hamilton, Ph.D. ... of,the audit committee. Dr. Hamilton has over 40 ... with particular expertise in the areas of,technology strategy ...
... depression based on financial woes, SAN DIEGO, Oct. ... at the San Diego Convention Center today for the,2008 ... economic,crisis causing new waves of anxiety disorders to ripple ... Sunday. More than 100 sessions,and symposia are scheduled throughout ...
... of Yale University,s,Prevention Research Center Links KIND Fruit + Nut ... DERBY, Conn., Oct.30 Snacking -- at least on the ... to a recently,completed pilot study at The Yale-Griffin Prevention Research ... Fruit & Nut Delight,Bars per day for eight weeks along ...
Cached Medicine News:Health News:B. Braun Medical Inc. Launches Ambulatory Surgical Center Website 2Health News:TeleHealth Names Matthew K. Barker to New Director of Marketing Position 2Health News:The Senior Citizens League's Comments on U.S. Supreme Court Case Wyeth v. Levine 2Health News:Arno Therapeutics Appoints William F. Hamilton to Board of Directors 2Health News:Arno Therapeutics Appoints William F. Hamilton to Board of Directors 3Health News:Psychiatric Congress Opens Amid Growing Climate of Economy-Driven Anxieties 2Health News:Psychiatric Congress Opens Amid Growing Climate of Economy-Driven Anxieties 3Health News:Daily Snack Bars May Facilitate Weight Loss 2Health News:Daily Snack Bars May Facilitate Weight Loss 3Health News:Daily Snack Bars May Facilitate Weight Loss 4
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
(Date:10/22/2014)... 22, 2014  Regulus Therapeutics Inc. (NASDAQ: ... leading the discovery and development of innovative ... has demonstrated human proof-of-concept with a microRNA ... RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ... virus infection ("HCV").  Interim results from the ...
(Date:10/20/2014)... octubre de 2014  PneumRx, Inc. ( www.pneumrx.com ... pulmonología intervencional, anunció hoy la conclusión de la ... antes de lo programado. El Estudio Clínico RENEW es ... investigación (IDE) aprobada por la FDA (Administración de ... de reducción de volumen pulmonar PneumRx RePneu, un ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3
... 17 The United States, fifth hand transplant ... to Massena, New York this week after a ... Kleinert Kutz and University of Louisville ... hand surgeons performed the Hondusky,s hand transplant at ...
... as international hub for collaborative research, biotech start-upsDETROIT, ... University research and technology park, will soon ... lab in Michigan. The Wayne County Stem Cell ... Executive Robert Ficano, who publicly announced Wayne County,s ...
Cached Medicine Technology:Fifth U.S. Hand Transplant Patient Heads Home to NY 2Fifth U.S. Hand Transplant Patient Heads Home to NY 3Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab' 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: